WATERTOWN — On Monday, December 1, Chris Nishan Garabedian, president, CEO and member of the board of directors of Sarepta Therapeutics will be the at the dinner meeting of St. James Armenian Church Men’s Club. The topic will be “The Age of Genetic-Based Medicine is Here, From Muscular Dystophy to Ebola.”
Garabedian has been a member of the board of directors of Sarepta Therapeutics since June 2010 and President and Chief Executive Officer since January 2011. Garabedian served as vice president of Corporate Strategy for Celgene Corporation, a publicly-traded integrated global biopharmaceutical company, from July 2007 to December 2010, where he was responsible for assessing all potential business development transactions.
From November 2005 to June 2007, Garabedian served as an independent consultant to early-stage biopharmaceutical companies. From 1997 to 1998 and from 1999 to November 2005, Garabedian worked at Gilead Sciences, Inc., a publicly-traded biopharmaceutical company, where he served in a number of global leadership roles, including as Vice President of Corporate Development, Vice President of Marketing, and Vice President of Medical Affairs. While at Gilead Sciences, Garabedian’s responsibilities included managing corporate development initiatives, including portfolio review and planning, mergers and acquisitions and in-licensing activities, and leading four global product launches. Garabedian also held various commercial roles at COR Therapeutics, Inc. from 1998 to 1999 and at Abbott Laboratories from 1994 to 1997.
He started his biopharmaceutical career as a consultant with Migliara/Kaplan Associates from 1991 to 1994. Garabedian received his BS in marketing from the University of Maryland.
The social hour starts with mezza at 6:15 p.m., followed by a traditional Armenian dinner at 7 p.m., $14 per person. The dinner meeting will be at the St. James Armenian Church, Charles Mosesian Cultural and Youth Center, Keljik Hall, 465 Mount Auburn St.
